Company attributes
Other attributes
Cambridge Bio-Augmentation Systems, or BIOS (as of December, 2018), is a company aiming to create neural interfaces between AI and the nervous system.
Founded by Emil Hewage and Oliver Armitage, the company has the goal to build a link between the body's nervous and external devices for the sake of aiding against chronic diseases. The link is not designed to communicate directly with the the spine or brain, but rather to decipher the signals that are sent to and from problematic/diseased organs or limbs, and then using a new signal to help treat the patient. The company's main targets are heart disease and diabetes.Another use for the neural link that BIOS offers is for a prosthetic interface device, or PID. With BIOS, a patient with a missing limb would be able to control an artificial body part.
BIOS uses machine learning to process high volumes of neural data to understand how each signal corresponds to a specific action in a patient. They are also making this data available to anybody involved in healthcare.
